Nymox Pharmaceutical (NYMX) Gross Profit Margin starting from the fourth quarter 2024 to fourth quarter 2023, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Nymox Pharmaceutical Corporation  (NYMX)


Nymox Pharmaceutical's Gross Profit Margin by quarter

Trends, Rankings, Statistics



NYMX Gross Profit Margin (Dec 31 2024)
Q4
0
Q3
0
Q2
0
Q1
(Dec 31 2023)
Q4
Y / Y Revenue Change -
Seq. Revenue Change -
Revenue In Millions $0.00
Gross Profit Margin -
Gross Profit Margin Total Ranking #
Gross Profit In Millions $0.00
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting fourth quarter 2024 Gross Profit Margin
Learn about Gross Margin
NYMX's Gross Profit Margin fourth quarter 2024 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry #
Healthcare Sector #
Overall # 0

Gross Profit Margin Statistics
High Average Low
77.78 % 54.61 % 20 %
(Dec 31 2019)   (Dec 31 2020)




Other Gross Profit Margin Profitability Ratios
NYMX's Cumulative Gross Profit Margin
In Vitro & In Vivo Diagnostic Substances Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
NYMX's Gross Profit Margin Profitability versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for NYMX's Competitors
Gross Profit Margin Profit Margin for Nymox Pharmaceutical's Suppliers
Gross Profit Margin Profit Margin for NYMX's Customers

You may also want to know
NYMX's Annual Growth Rates NYMX's Profitability Ratios NYMX's Asset Turnover Ratio NYMX's Dividend Growth
NYMX's Roe NYMX's Valuation Ratios NYMX's Financial Strength Ratios NYMX's Gross Profit Growth
NYMX's Roa NYMX's Inventory Turnover Ratio NYMX's Growth Rates NYMX's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2024, within In Vitro & In Vivo Diagnostic Substances Industry Gross Profit MarginDec 31 2024 MRQ Gross ProfitDec 31 2024 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.